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Background/aim: Isotretinoin is an effective drug utilized in the management of acne vulgaris and is known to cause dry mouth. In this
study, we aimed to evaluate this effect of isotretinoin on the salivary gland function in patients with acne vulgaris using technetium-99m
(Tc-99m) pertechnetate imaging of the salivary glands.
Materials and methods: The study population consisted of 28 patients with acne vulgaris (6 males and 22 females, mean age 20.2 ±
2.3 years), who were treated with isotretinoin for 6 months. We performed radionuclide imaging of the salivary glands pretreatment
and at months 3 and 6 of treatment. After 185 MBq (5 mCi) of Tc-99m pertechnetate was intravenously administered, imaging of the
salivary glands was performed over a 25-min period. We measured the following glandular function parameters for the parotid and
submandibular salivary glands via time-activity curves: uptake ratio, maximum accumulation, and ejection fraction.
Results: Statistically significant differences were observed in the values obtained at months 3 and 6 of treatment, compared with the
pretreatment values.
Conclusion: This study demonstrated that radionuclide imaging of the salivary glands can clearly show the glandular functions that are
affected by drugs such as isotretinoin.
Key words: Radionuclide imaging of salivary glands, technetium-99m pertechnetate, isotretinoin, acne vulgaris

1. Introduction
The subjective feeling of dry mouth, xerostomia, has a
variety of causes, such as Sjögren’s syndrome, external
radiation to the head and neck, chemotherapy, various
drugs, and some viral infections, and it may derive
from a decrease in the production of saliva (1–3). Acne
vulgaris of unknown etiology is a chronic inflammatory
disease of the pilosebaceous follicles that is seen in young
adulthood. Although it is not life-threatening, it can leave
long-term physical and psychological damage. Therefore,
early and effective treatment is important to reduce the
severity and recurrence of the disease (4). Isotretinoin
is an effective drug against the factors involved in acne
pathogenesis and provides long-term disease remission.
However, it is a common cause of dryness of the mouth
and changes in the oral and lip mucosa (5). Radionuclide
imaging of salivary glands with high sensitivity is a
* Correspondence: ebruorsal@gmail.com
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valuable technique for use in the definition of the etiology
and the degree of salivary dysfunction. This technique
is noninvasive and is suitable for normal physiology.
Uptake of technetium-99m (Tc-99m) pertechnetate by
the salivary glands is observed following intravenous
(i.v.) injection. Quantitative functional data, for example
uptake ratio, concentration, and excretion fraction, can be
obtained via radionuclide imaging of the salivary glands
(6–8). Evaluation of salivary gland function according
to objective criteria, rather than subjective complaints,
may provide an accurate assessment of patients taking
isotretinoin and suffering from dry mouth. Therefore,
the aim of this study was to compare the quantitative
parameters of salivary gland functions in patients taking
isotretinoin for acne vulgaris, both before treatment and
at the 3rd and 6th months of treatment, using Tc-99m
pertechnetate imaging.

ÖRSAL et al. / Turk J Med Sci

Figure 1. ROIs on the summation image obtained by radionuclide
imaging of salivary glands. ROI 1- Right parotid gland, ROI 2Left parotid gland, ROI 3- Right submandibular gland, ROI 4Left submandibular gland, ROI 5- Background.
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2. Materials and methods
2.1. Patients
The study population consisted of 28 patients with acne
vulgaris (22 females and 6 males), with a mean age of
20.2 ± 2.3 years (range: 18 to 27 years). We performed
radionuclide imaging of the patients’ salivary glands before
they began treatment, after which all patients received
the clinically recommended oral dose of isotretinoin, 0.5
mg kg–1 day–1, for 6 months (9). Controlled radionuclide
imaging of the salivary glands was then performed at
months 3 and 6 of treatment. The patients had neither a
history of radiation treatment and head or neck surgery
nor any connective tissue or systemic disease. All patients
provided written informed consent prior to the study,
which was approved by the ethics committee of Atatürk
University.
2.2. Radionuclide imaging of salivary glands
All patients were placed in the supine position and the
head was hyperextended prior to i.v. administration of
185 MBq (5 mCi) of Tc-99m pertechnetate. A singlehead gamma camera (GE-Starcam 4000 XR/T, UK) with a
parallel-hole, low-energy, and high-resolution collimator
was used, and this was centered on a photo peak of Tc99m. The data were acquired as 25 frames of 60 s per frame
in a 1.33 zoom and a 128 matrix × 128 matrix. Lemon juice
was orally administered for salivary gland stimulation at 20
min after the injection. Similar protocols have been used
in other studies (7,8,10,11). The repeated measurements
were well tolerated in all patients.
2.3. Semiquantitative analysis
Regions of interest (ROIs) were drawn around the parotid
and submandibular glands on collected images for
semiquantitative analysis. In addition, a background ROI
was placed in the temporal area, and time-activity curves
of salivary glands were generated (Figure 1).
Figure 2 shows the definition of the following points
on the time-activity curve: a) vascular perfusion, at 1 min;
b) the maximum prestimulation count; c) the background
count at the time of peak activity; d) the minimum
poststimulation count. The following functional glandular
parameters were measured for the salivary glands: uptake
ratio (UR) = b / c, maximum accumulation (MA%) = (b
– a) / b × 100, and ejection fraction (EF%) = (b – d) /b ×
100 (6,10,17).
2.4. Statistical analysis
We used SPSS for statistical analysis and calculated
weighted means and standard deviations. Groups were
compared using repeated measures analysis of variance.
For variables without a normal distribution (i.e. MA% and
EF% of the left parotid gland, MA% and UR of the right
submandibular gland) we used Friedman analysis and
carried out further analysis using the Wilcoxon test. The
significance level was taken as P < 0.05.
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Figure 2. Time-activity curves obtained by radionuclide imaging
of salivary glands. a- Vascular perfusion at 1 min, b- Maximum
prestimulation count, c- Background count at the time of peak
activity, d- Minimum poststimulation count, P- Parotid gland,
Sm- Submandibular gland, Bg- Background.

3. Results
We included 28 patients (6 males and 22 females) treated
with isotretinoin for acne vulgaris this study. The UR,
MA%, and EF% values measured for the salivary glands
are presented in the Table. The values obtained at months
3 and 6 of treatment were compared with pretreatment
values. The UR, MA%, and EF% outcomes of the right
and left parotid glands were decreased at months 3 and

675

ÖRSAL et al. / Turk J Med Sci
Table. The values obtained at months 3 and 6 of treatment were compared with pretreatment values. *: Friedman
analysis of variance. UR, Uptake ratio; MA%, maximum accumulation; EF%, ejection fraction; RP, right parotid; LP,
left parotid; RSbm, right submandibular; LSbm, left submandibular. Data are expressed as mean ± standard deviation.

Parameter

UR

MA%

EF%

Gland

Pretreatment
(n = 28)

Third month of
treatment
(n = 28)

Sixth month of
treatment
(n = 28)

P

RP

6.76 ± 1.31

4.57 ± 1.34

3.63 ± 1.41

0.0001

LP

6.45 ± 1.38

4.46 ± 1.41

3.71 ± 1.44

0.0001

RSbm

3.04 ± 1.13

2.04 ± 0.82

1.58 ± 0.72

0.0001*

LSbm

2.63 ± 1.51

1.86 ± 1.34

1.47 ± 1.31

0.0001

RP

60.21 ± 8.99

50.17 ± 10.98

45.15 ± 11.95

0.0001

LP

59.52 ± 8.85

50.31 ± 11.34

44.18 ± 10.81

0.0001*

RSbm

37.05 ± 11.72

24.81 ± 10.97

16.46 ± 8.03

0.0001*

LSbm

38.64 ± 12.69

27.61 ± 13.54

20.16 ± 9.97

0.0001

RP

55.62 ± 9.32

44.18 ± 11.55

38.12 ± 10.11

0.0001

LP

55.00 ± 9.41

41.95 ± 12.75

35.84 ± 12.92

0.0001*

RSbm

36.30 ± 1.31

25.70 ± 1.53

21.87 ± 1.54

0.002

LSbm

36.88 ± 10.99

27.76 ± 11.04

21.72 ± 8.3

0.0001

6 of treatment (P < 0.0001 for all). In addition, there were
significant decreases in the UR, MA%, and EF% of the
right and left submandibular glands at months 3 and 6
of treatment when compared to pretreatment values (P <
0.002 for all).
4. Discussion
Drug usage is one of the most common reasons for
reduced salivation. Systemic retinoids, used in the
treatment of acne vulgaris, are a common cause of dryness
of the mouth and changes in oral and lip mucosa (2).
Isotretinoin is a drug that can be safely utilized to treat
cases of acne vulgaris, with sufficient monitoring, when the
benefits outweigh the risks (13). Recently, dermatologists
have increasingly used isotretinoin to treat acne vulgaris
that has not responded to other systemic therapies (12).
Isotretinoin is effective, but some patients may experience
a side effect of dry mouth due to a decrease in salivary
secretion. The changes in salivary secretion may be due
to the effect of retinoids on epidermal cell turnover rate
(14). Lupi-Pegurier et al. (15) conducted salivary tests in
patients treated with isotretinoin for acne vulgaris using
whole stimulated saliva samples. To obtain these samples,
the patients chewed a piece of paraffin wax for 5 min and
spat into a small graduated tube, after which the flow rate
was calculated. The salivary flow gradually decreased with
time. Oikarinen et al. (16) assessed changes in salivary
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flow during treatment in patients treated for acne vulgaris
with systemic isotretinoin for 3 months. They found
that the flow rate of stimulated saliva diminished during
treatment. In our study, we observed similar findings;
gradual decreases in salivary gland function were
determined in acne vulgaris patients during isotretinoin
treatment.
The salivary glands may be assessed using computerized
tomography and sialography. However, neither of these
techniques enables quantitative evaluation of salivary gland
functions. Furthermore, sialography is hard and painful
for the patients, due to cannulization of the salivary gland
ducts (8). An alternative useful technique is radionuclide
imaging, which allows a functional assessment of the
salivary glands. Radionuclide imaging may be carried
out easily and is of low dosimetry. It is well tolerated by
patients because it is suitable for normal physiology (17–
22). A literature review of the quantitative evaluation of
salivary gland functions created from dynamic studies
showed that most functional parameters, for example
percentage uptake, concentration, and excretion fractions,
were generated from individual salivary gland timeactivity curves (6–8,23–25). Booker et al. (6) studied the
diversity of UR, MA, and EF in a group of 83 patients with
xerostomia, including a subset of 40 patients with Sjögren’s
syndrome and a group of 26 healthy volunteers. Anjos
et al. performed radionuclide imaging of salivary glands
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to acquire reference values of salivary gland uptake and
excretion fraction in 50 healthy volunteers (7). In our
study, evaluation of salivary gland function was performed
by radionuclide imaging, and we found that there were
significant decreases in the salivary gland functions of
patients using isotretinoin at months 3 and 6 compared
to pretreatment values. This study was the first to conduct
an objective evaluation of salivary gland function with
radionuclide imaging in patients taking isotretinoin for
acne vulgaris.

In conclusion, we recommend salivary gland
scintigraphy as an effective, easy, and reproducible
diagnostic method that can be used to assess the effects
of drugs such as isotretinoin, which affect salivary gland
functions.
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